BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Conlon JM, O'Harte FPM, Flatt PR. Dual-agonist incretin peptides from fish with potential for obesity-related Type 2 diabetes therapy - A review. Peptides 2021;147:170706. [PMID: 34861327 DOI: 10.1016/j.peptides.2021.170706] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Boutin JA, Leprince J. Why Search for Alternative GPCR Agonists? Receptors 2023;2:16-33. [DOI: 10.3390/receptors2010002] [Reference Citation Analysis]
2 Wang J, Liu C, Yang H, Ma T, Liu Y, Chen F. Intramolecularly lactam stapled oxyntomodulin analogues inhibit cancer cell proliferation in vitro. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.107920] [Reference Citation Analysis]
3 Chu L, Terasaki M, Mattsson CL, Teinturier R, Charbord J, Dirice E, Liu KC, Miskelly MG, Zhou Q, Wierup N, Kulkarni RN, Andersson O. In vivo drug discovery for increasing incretin-expressing cells identifies DYRK inhibitors that reinforce the enteroendocrine system. Cell Chem Biol 2022;29:1368-1380.e5. [PMID: 35998625 DOI: 10.1016/j.chembiol.2022.08.001] [Reference Citation Analysis]